CIBC Innovation Banking Provides Growth Capital to InsightRX
The Californer/10271234

SAN FRANCISCO ~ In a recent announcement, CIBC Innovation Banking revealed that it has provided growth financing to InsightRX, a San Francisco-based software company. InsightRX is known for its innovative use of quantitative pharmacology and artificial intelligence (AI) to enhance therapeutic decision-making from the early stages of drug development to the point of patient care.

InsightRX's unique approach involves utilizing patient-specific data and quantitative models to tailor dosing for complex treatments such as antibiotics, chemotherapeutic agents, and immunosuppressants. By incorporating AI technology, the company also empowers data scientists in analyzing clinical trial data, aiding in trial design, understanding dose-exposure-response relationships, and refining dosing strategies for regulatory submissions.

According to Sirj Goswami, Ph.D., CEO and co-founder of InsightRX, their goal is to shift away from the traditional "one-size-fits-all" approach in drug dosing towards a more individualized treatment paradigm. This not only benefits patient care but also has a significant impact on the introduction of new drugs to the market. To achieve their strategic vision of transforming patient care, InsightRX sought out financing from CIBC and found them to be an ideal partner due to their intellectual curiosity about the intricacies of their business and thoughtful approach.

More on The Californer

• Glossa Launches Slack Integration to Capture Requirements Where Teams Work
• PowerTribe Releases New Heavy Metal Single "The Earthlings Have Died"
• California: Following LA fires, Governor Newsom extends key provision to fast‑track wildfire safety window, protecting more communities across the state
• Australian Soulstress NARDIA returns to the U.S. for her January 2026 Tour
• California advances Jobs First agenda, expands career pathways and worker protections statewide

John Flemming, managing director of CIBC Innovation Banking's Seattle office expressed excitement about working with InsightRX's leadership team. He believes that their use of AI technology will pave the way for advancements in drug development within biopharma clinical trials and improve healthcare providers' ability to ensure optimal drug dosing for patients. Flemming also noted that InsightRX will play a crucial role in enhancing the development of new therapies that prioritize patient safety throughout the healthcare drug development and delivery chain.

With this new financing from CIBC Innovation Banking, InsightRX is well-positioned to continue its groundbreaking work in revolutionizing drug dosing and improving patient outcomes. As they continue to lead the way in this field, InsightRX and CIBC are poised to make a significant impact on the future of healthcare.

---

Show All News | Report Violation